Literature DB >> 11133228

Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes.

P Narayan1, R M Mentzer, R D Lasley.   

Abstract

Reactive oxygen species (ROS) formation following brief periods of ischemia or hypoxia is thought to be the underlying cause of myocardial stunning. Adenosine A1 receptor activation prior to ischemia/hypoxia attenuates stunning, although the mechanism for this effect remains unknown. Isolated rat ventricular myocytes loaded with the ROS-sensitive indicator dichlorofluorescin were subjected to 30 min glucose-free hypoxia followed by reoxygenation. Intracellular ROS increased approximately 175% (from pre-hypoxic levels) during reoxygenation while cell shortening decreased approximately 50%. In myocytes pretreated with the adenosine A1 agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA), reoxygenation-induced ROS formation was attenuated by 40% and stunning was attenuated by 50% (compared to untreated myocytes). The mitochondrial K(ATP) channel opener diazoxide mimicked the effects of CCPA. Pretreatment with the mitochondrial K(ATP) channel blocker 5-hydroxydecanoate, or the non-selective K(ATP) channel blocker glibenclamide, blocked the effects of CCPA. These results suggest that adenosine A1 receptor activation attenuates stunning by reducing ROS formation. These effects of A1 receptor activation appear to be dependent on the opening of K(ATP) channels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11133228     DOI: 10.1006/jmcc.2000.1282

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  20 in total

1.  Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.

Authors:  Sabzali A Javadov; Samantha Clarke; Manika Das; Elinor J Griffiths; Kelvin H H Lim; Andrew P Halestrap
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

2.  Pretreatment with adenosine and adenosine A1 receptor agonist protects against intestinal ischemia-reperfusion injury in rat.

Authors:  V Haktan Ozacmak; Hale Sayan
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

3.  A hypoxic episode during cardiogenesis downregulates the adenosinergic system and alters the myocardial anoxic tolerance.

Authors:  Elodie Robin; Fabrice Marcillac; Eric Raddatz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-01-28       Impact factor: 3.619

4.  Linagliptin prevents atrial electrical and structural remodeling in a canine model of atrial fibrillation.

Authors:  Tazuru Igarashi; Shinichi Niwano; Hiroe Niwano; Tomoharu Yoshizawa; Hironori Nakamura; Hidehira Fukaya; Tamami Fujiishi; Naruya Ishizue; Akira Satoh; Jun Kishihara; Masami Murakami; Junya Ako
Journal:  Heart Vessels       Date:  2018-05-02       Impact factor: 2.037

5.  Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts.

Authors:  Zhichao Zhou; Uthra Rajamani; Hicham Labazi; Stephen L Tilley; Catherine Ledent; Bunyen Teng; S Jamal Mustafa
Journal:  Purinergic Signal       Date:  2015-04-25       Impact factor: 3.765

6.  Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.

Authors:  Samantha J Clarke; Igor Khaliulin; Manika Das; Joanne E Parker; Kate J Heesom; Andrew P Halestrap
Journal:  Circ Res       Date:  2008-03-20       Impact factor: 17.367

Review 7.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

8.  Adenine nucleotide translocase mediates the K(ATP)-channel-openers-induced proton and potassium flux to the mitochondrial matrix.

Authors:  Dalia M Kopustinskiene; Adolfas Toleikis; Nils-Erik L Saris
Journal:  J Bioenerg Biomembr       Date:  2003-04       Impact factor: 2.945

9.  Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.

Authors:  S-L Puhl; A Kazakov; A Müller; P Fries; D R Wagner; M Böhm; C Maack; Y Devaux
Journal:  Br J Pharmacol       Date:  2015-11-16       Impact factor: 8.739

10.  A1AR-mediated renal protection against ischemia/reperfusion injury is dependent on HSP27 induction.

Authors:  Bin Xiong; Min Li; Shulin Xiang; Lin Han
Journal:  Int Urol Nephrol       Date:  2018-02-26       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.